Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR1900020720Phase 4Recruiting
Phase 4, randomised, double-blind trial of Yangxindingji capsule in Premature ventricular complexes (PVC) (2 arms), sponsored by Beijing Chaoyang Hospital. Primary endpoint: Total effective rate of ventricular premature beats at week 8. Started Sep 2017; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR1900020720.